055 The impact of methotrexate and targeted immunosuppression on cellular and humoral immune responses to COVID-19 vaccine BNT162b2: a cohort study

por Mahil, S.K., Bechman, K., Raharja, A., Domingo-Vila, C., Brown, M., Cope, A., Malim, M., Pollock, E., Seow, J., Barker, J., Norton, S., Galloway, J., Doores, K., Tree, T., Smith, C.
Publicado 2021

P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS

por Harrington, P., Saunders, J., Saha, C., Sheikh, A., Dillon, R., Raj, K., Cadman-Davies, L., Lechmere, T., Khan, H., Woodley, C., Asirvatham, S., Curto-Garcia, N., O’Sullivan, J., Kordasti, S., Radia, D., McLornan, D., Malim, M., Doores, K., Harrison, C., de Lavallade, H.
Publicado 2022